Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

The impact of medication reconciliation and review in patients using oral chemotherapy.

Darcis E, Germeys J, Stragier M, et al. The impact of medication reconciliation and review in patients using oral chemotherapy. J Oncol Pharm Pract. 2023;29(2):270-275. doi:10.1177/10781552211066959.

Save
Print
March 1, 2023
Darcis E, Germeys J, Stragier M, et al. J Oncol Pharm Pract. 2023;29(2):270-275.
View more articles from the same authors.

Medication errors are common in patients using oral chemotherapy. In this study, a hospital pharmacist identified medication discrepancies in nearly 75% of patients starting oral chemotherapy, with an average of two discrepancies per patient. The pharmacist followed up with the patient’s oncologist via the electronic health record, and the oncologist could accept or reject the pharmacist’s recommendation. Patient outcomes were not evaluated in this study.

Save
Print
Cite
Citation

Darcis E, Germeys J, Stragier M, et al. The impact of medication reconciliation and review in patients using oral chemotherapy. J Oncol Pharm Pract. 2023;29(2):270-275. doi:10.1177/10781552211066959.